Marc Shuman

1.4k citations
20 papers · 1.1k indexed · h-index 11
Topics
Glioma Diagnosis and Treatment (5 papers)CNS Lymphoma Diagnosis and Treatment (4 papers)Inflammatory mediators and NSAID effects (3 papers)

In The Last Decade

Marc Shuman

20 papers receiving 1.0k citations

Peers

Marc Shuman
Comparison fields: 5 of 87
  • Molecular Biology 396
  • Neurology 329
  • Pathology and Forensic Medicine 317
  • Genetics 259
  • Cancer Research 257
Replace Uwe Kordes with:
Uwe Kordes Germany
Karin Bink Germany
Katrin M. Carlson United States
Jacques Vargaftig France
Kirsten van Lom Netherlands
Richard J. Dahl United States
Markus Kreuz Germany
Véronique Laithier France
Sergei Syrbu United States
Debra Saxe United States
Marc Shuman relative to Uwe Kordes Germany Uwe Kordes's profile →
Citations per field
00.5×1.7×
Uwe Kordes · 1×
Citations per year

Countries citing papers authored by Marc Shuman

Since Specialization
Citations

This map shows the geographic impact of Marc Shuman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Shuman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Shuman more than expected).

Fields of papers citing papers by Marc Shuman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Shuman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Shuman. The network helps show where Marc Shuman may publish in the future.

Co-authorship network of co-authors of Marc Shuman

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Shuman. A scholar is included among the top collaborators of Marc Shuman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Shuman. Marc Shuman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 16
3 236
4 52
5 243
6 2
7 8
8 150
9
Additive effect of the combination of 5-aza-2’-deoxycytidine and valproic acid in leukemia cell systems
5
10 5
11 8
12 34
13 5
14 12
15 7
16 132
17 38
18 109
19 21
20 1

About Marc Shuman

Marc Shuman is a scholar working on Genetics, Toxicology and Hematology, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Genetics (259 citations), Neurology (329 citations) and Pathology and Forensic Medicine (317 citations). Marc Shuman has collaborated with scholars based in United States, Sweden and Denmark. Frequent co-authors include James L. Rubenstein, O.O. Melnyk, M B Zimmerman, Chris Haqq, Arthur Shen, Michael D. Prados, Jon Karch, Jane Fridlyand, Michael McDermott and Long-Cheng Li. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026